GATA1 and irritable bowel syndrome: Although this mechanism needs to be further confirmed in other animal models (e.g., a stress-induced model of chronic visceral pain), our findings provide a probable potential therapeutic strategy by targeting GATA1 and the p2x7r locus binding in the clinical management of patients with gastrointestinal diseases such as IBS.